BioLASCO Taiwan Co., Ltd. (TPEX:6662)

Taiwan · Delayed Price · Currency is TWD

28.50

-0.20 (-0.70%)

Sep 15, 2026, 12:16 PM CST

Market Cap	729.94M -15.9%
Revenue (ttm)	258.04M -8.7%
Net Income	40.89M -16.1%
EPS	1.59 -16.3%
Shares Out	25.61M
PE Ratio	17.92
Forward PE	n/a
Dividend	1.50 (5.26%)
Ex-Dividend Date	Aug 7, 2026

Volume	2,000
Open	28.60
Previous Close	28.70
Day's Range	28.50 - 28.60
52-Week Range	28.00 - 34.50
Beta	0.16
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About BioLASCO Taiwan

BioLASCO Taiwan Co., Ltd. operates an animal breeding center to produce specific pathogen-free laboratory animals in Taiwan and internationally. The company offers lab animals, such as rat, mice, and others, as well as surgical services; and rodents housing, washing solutions, workstations, animal housing and management solutions, lab animal research equipment, clean solution, preclinical imaging system, and experimental equipment. It also offers reagents, including lab animal diagnostic reagent, endotoxin testing system, portable endotoxin tes... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1990

Employees 91

Stock Exchange Taipei Exchange

Ticker Symbol 6662

Full Company Profile

Financial Performance

In 2025, BioLASCO Taiwan's revenue was 262.66 million, a decrease of -10.20% compared to the previous year's 292.50 million. Earnings were 42.43 million, a decrease of -3.63%.

Financial Statements